← Back to headlines
Zealand Pharma Reports 17% Weight Loss in Late-Stage GLP-1 Trial with Boehringer
Zealand Pharma announced that its GLP-1 drug, developed in collaboration with Boehringer Ingelheim, achieved an average of 17% weight loss in participants during a late-stage clinical trial.
28 Apr, 16:03 — 28 Apr, 16:03
Sources
Showing 1 of 1 sources
